152 related articles for article (PubMed ID: 22581787)
1. MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores.
Nagarajan R; Margolis D; Raman S; Sarma MK; Sheng K; King CR; Verma G; Sayre J; Reiter RE; Thomas MA
J Magn Reson Imaging; 2012 Sep; 36(3):697-703. PubMed ID: 22581787
[TBL] [Abstract][Full Text] [Related]
2. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
3. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
4. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
6. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
Somford DM; Hambrock T; Hulsbergen-van de Kaa CA; Fütterer JJ; van Oort IM; van Basten JP; Karthaus HF; Witjes JA; Barentsz JO
Invest Radiol; 2012 Mar; 47(3):153-8. PubMed ID: 22293513
[TBL] [Abstract][Full Text] [Related]
7. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
[TBL] [Abstract][Full Text] [Related]
8. Role of endorectal magnetic resonance spectroscopic imaging in two different Gleason scores in prostate cancer.
Nagarajan R; Margolis D; McClure T; Raman S; Thomas MA
Med Princ Pract; 2011; 20(5):444-8. PubMed ID: 21757934
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T.
Thörmer G; Otto J; Horn LC; Garnov N; Do M; Franz T; Stolzenburg JU; Moche M; Kahn T; Busse H
Acta Radiol; 2015 Jan; 56(1):121-8. PubMed ID: 24504488
[TBL] [Abstract][Full Text] [Related]
10. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
[TBL] [Abstract][Full Text] [Related]
12. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.
Kumar V; Jagannathan NR; Kumar R; Das SC; Jindal L; Thulkar S; Gupta SD; Dwivedi SN; Roell S; Hemal AK; Gupta NP
Magn Reson Imaging; 2006 Jun; 24(5):541-8. PubMed ID: 16735174
[TBL] [Abstract][Full Text] [Related]
13. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
Riches SF; Payne GS; Morgan VA; Sandhu S; Fisher C; Germuska M; Collins DJ; Thompson A; deSouza NM
AJR Am J Roentgenol; 2009 Dec; 193(6):1583-91. PubMed ID: 19933651
[TBL] [Abstract][Full Text] [Related]
14. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
Shukla-Dave A; Hricak H; Moskowitz C; Ishill N; Akin O; Kuroiwa K; Spector J; Kumar M; Reuter VE; Koutcher JA; Zakian KL
Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357
[TBL] [Abstract][Full Text] [Related]
15. Comparison between Gleason score and apparent diffusion coefficient obtained from diffusion-weighted imaging of prostate cancer patients.
Caivano R; Rabasco P; Lotumolo A; Cirillo P; D'Antuono F; Zandolino A; Villonio A; Macarini L; Salvatore M; Cammarota A
Cancer Invest; 2013 Nov; 31(9):625-9. PubMed ID: 24138289
[TBL] [Abstract][Full Text] [Related]
16. Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla.
Mazaheri Y; Shukla-Dave A; Goldman DA; Moskowitz CS; Takeda T; Reuter VE; Akin O; Hricak H
Magn Reson Imaging; 2019 Jan; 55():93-102. PubMed ID: 30176373
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: correlation with histopathology.
Styles C; Ferris N; Mitchell C; Murphy D; Frydenberg M; Mills J; Pedersen J; Bergen N; Duchesne G
J Med Imaging Radiat Oncol; 2014 Aug; 58(4):439-48. PubMed ID: 24935089
[TBL] [Abstract][Full Text] [Related]
18. Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).
Dwivedi DK; Kumar R; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
NMR Biomed; 2016 Mar; 29(3):232-8. PubMed ID: 26730884
[TBL] [Abstract][Full Text] [Related]
19. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
Kagebayashi Y; Nakai Y; Matsumoto Y; Samma S; Miyasaka T; Nakagawa H
Hinyokika Kiyo; 2012 Aug; 58(8):405-8. PubMed ID: 23052263
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging.
Costouros NG; Coakley FV; Westphalen AC; Qayyum A; Yeh BM; Joe BN; Kurhanewicz J
AJR Am J Roentgenol; 2007 Mar; 188(3):812-6. PubMed ID: 17312072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
